Find all needed information about Filgrastim Support. Below you can see links where you can find everything you want to know about Filgrastim Support.
https://www.neupogen.com/resources-support/
x Indications. Patients with cancer receiving strong chemotherapy . NEUPOGEN ® is a prescription medicine used to help reduce the chance of infection due to a low white blood cell count, in people with certain types of cancer (non-myeloid) who receive anti-cancer medicines (chemotherapy) that can cause fever and a low blood cell count. Read More. Patients with Acute Myeloid Leukemia (AML ...
https://www.neupogenhcp.com/support-materials
Cancer Support Community TM (CSC) CSC, one of the largest professionally-led networks of cancer support worldwide, provides emotional and social support for people affected by cancer. The organization includes community-based centers and online …
https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.11516
Filgrastim support was given to patients in the low‐risk group only if there was delayed hematologic recovery or if the patient had an episode of febrile neutropenia (temperature > 38.3 °C and ANC ≤ 0.5 × 10 9 /L), and prophylactic filgrastim was continued in all remaining chemotherapy cycles.
https://www.neupogen.com/contact-us/
The last dose of NEUPOGEN ® (filgrastim) should be injected at least 24 hours before your next dose of chemotherapy. NEUPOGEN ® should be injected at the same time each day. If you miss a dose, contact your doctor or nurse. You must always use the correct dose of NEUPOGEN ®.Too little may not protect you against infections, and too much may cause too many neutrophils to be in your blood.
https://www.drugs.com/cdi/filgrastim-injection.html
Sep 11, 2019 · Uses of Filgrastim Injection: It is used to lower the chance of getting an infection in people with bone marrow problems caused by chemo. It is used to raise the number of white blood cells in certain patients. It is used in patients who have been exposed to certain doses of radiation.9/10
https://www.zarxio.com/resources/patient-support/
Sickle cell crisis, in some cases fatal, has been reported with the use of filgrastim products in patients with sickle cell trait or sickle cell disease. Glomerulonephritis has occurred in patients receiving filgrastim products. The diagnoses were based upon azotemia, hematuria (microscopic and macroscopic), proteinuria, and renal biopsy.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996561/
To improve long-term outcomes for Burkitt leukaemia/lymphoma (BL) or aggressive lymphomas in adults, we assessed the benefit of adding rituximab and filgrastim support to a dose-dense modified chemotherapy regimen from the Cancer and Leukemia Group B (CALGB) 9251 trial.Cited by: 58
http://chemocare.com/chemotherapy/drug-info/Pegfilgrastim.aspx
Pegfilgrastim is a support medication. The following list includes side effects attributed to pegfilgrastim. Other side effects experienced were attributed to the chemotherapy and/or the disease. The following side effects are common (occurring in greater than 30%) for patients taking pegfilgrastim:
Need to find Filgrastim Support information?
To find needed information please read the text beloow. If you need to know more you can click on the links to visit sites with more detailed data.
